Withdrawal: Makena
Apr. 2023Pharmacy Updates
On March 7, 2023, Covis Pharma announced that it is withdrawing Makena (hydroxyprogesterone caproate injection; also referred to as 17-OHPC) from the market. This drug is used to reduce the risk of preterm birth in women who are pregnant with one baby and have a history of spontaneous preterm birth. Read more about the Makena withdrawal.
Recent Announcements
CME Webinar: Getting it Right from the Start: Identifying Patient Advanced Care Directives
Please join us for a live, CME-accredited webinar on Thursday, Oct. 15, 2026 that will educate providers on identifying advanced directives and surrogate decision makers on admission.Oct. 2026Education/Webinars
CME Webinar: Navigating Grief Conversations
Please join us for a live, CME-accredited webinar on Thursday, Nov. 12, 2026, that will enhance your confidence and effectiveness in supporting patients dealing with loss & grief.Oct. 2026Education/Webinars
UPMC Health Plan Tapestry Link live training session
UPMC Health Plan Tapestry Link is scheduled to go live on Tuesday, Dec. 1, 2026. To help prepare you for this launch we will be hosting a live training session on Wednesday, Nov. 4, 2026, from noon to 1 p.m. to help you familiarize yourself with the platform. During this training we will discuss:Sep. 2026Education/Webinars